Two Sigma Investments
CPIX icon

Two Sigma Investments’s Cumberland Pharmaceuticals CPIX Stock Holding History

Two Sigma Investments’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36K Sell
11,085
-13,400
-55% -$51.6K ﹤0.01% 4483
2025
Q4 		$97.5K Sell
24,485
-13,106
-35% -$38.8K ﹤0.01% 3859
2025
Q3 		$117K Buy
37,591
+5,326
+17% +$17.7K ﹤0.01% 3452
2025
Q2 		$108K Buy
32,265
+9,510
+42% +$45K ﹤0.01% 2988
2025
Q1 		$96.3K Sell
22,755
-14,894
-40% -$61.8K ﹤0.01% 2970
2024
Q4 		$89.2K Buy
37,649
+18,271
+94% +$26.9K ﹤0.01% 2983
2024
Q3 		$24.8K Buy
19,378
+48
+0.2% +$66 ﹤0.01% 3012
2024
Q2 		$29.6K Sell
19,330
-13,100
-40% -$20.6K ﹤0.01% 2918
2024
Q1 		$54.5K Sell
32,430
-600
-2% -$1.2K ﹤0.01% 2880
2023
Q4 		$59.2K Sell
33,030
-200
-0.6% -$367 ﹤0.01% 2982
2023
Q3 		$62.8K Hold
33,230
– – ﹤0.01% 2793
2023
Q2 		$48.8K Sell
33,230
-200
-0.6% -$345 ﹤0.01% 2835
2023
Q1 		$65.2K Sell
33,430
-5,000
-13% -$11.9K ﹤0.01% 2720
2022
Q4 		$86.5K Sell
38,430
-6,785
-15% -$15.7K ﹤0.01% 2526
2022
Q3 		$109K Sell
45,215
-6,287
-12% -$14.8K ﹤0.01% 2218
2022
Q2 		$107K Sell
51,502
-37,581
-42% -$86.9K ﹤0.01% 2261
2022
Q1 		$251K Buy
89,083
+6,163
+7% +$20.5K ﹤0.01% 2272
2021
Q4 		$387K Buy
+82,920
New +$283K ﹤0.01% 3462
2014
Q1 		– Sell
-38,485
Closed -$197K – 2024
2013
Q4 		$197K Buy
38,485
+14,585
+61% +$71.2K ﹤0.01% 2015
2013
Q3 		$108K Sell
23,900
-1,300
-5% -$6.47K ﹤0.01% 1735
2013
Q2 		$129K Buy
+25,200
New +$125K ﹤0.01% 1864

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Two Sigma Investments's CPIX Position: Q1 2026 in Review

Two Sigma Investments reduced its Cumberland Pharmaceuticals (CPIX) stake by 55% in Q1 2026, selling an estimated $51.6K and leaving 11,085 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #4483.

Two Sigma Investments first reported a position in CPIX in Q2 2013 and has held it in 21 quarters since. The position peaked at $387K in Q4 2021. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Two Sigma Investments held 11,085 shares of Cumberland Pharmaceuticals worth $36K as of Q1 2026.
  • Two Sigma Investments sold 13,400 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $51.6K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4483 holding.
  • Two Sigma Investments first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
  • Two Sigma Investments's Cumberland Pharmaceuticals position peaked at $387K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.